Medtronic's Financial Strategy to Be Discussed at Upcoming Investor Conferences

Medtronic's Financial Strategy Takes Center Stage at Upcoming Investor Conferences

Medtronic plc, a global leader in healthcare technology, is set to spotlight its financial strategy with Thierry Piéton, the company’s Executive Vice President and Chief Financial Officer, participating in key fireside chats at two notable investor conferences. Scheduled for March 10 and March 11, 2026, these events—the Barclays 28th Annual Global Healthcare Conference and the Leerink Partners Global Healthcare Conference—will provide a platform for the company to outline its financial direction and innovative initiatives. Given Medtronic’s commitment to addressing global health challenges, Piéton's discussions are expected to offer insights into how financial management aligns with the company’s broader mission of improving patient outcomes.

Medtronic operates in a dynamic environment, focusing on cutting-edge solutions for an array of health conditions including cardiac devices, surgical robotics, and insulin pumps. The company prides itself on engineering outcomes that significantly enhance the lives of patients, with a remarkable impact of affecting two individuals every second. During the upcoming conferences, Piéton is likely to emphasize the company's ongoing commitment to innovation and efficiency, demonstrating how strategic financial planning plays a crucial role in supporting Medtronic's healthcare advancements. The live webcasts of these sessions, available on the company's investor relations webpage, will also allow stakeholders to engage with the discussions actively.

Emphasizing Medtronic's global reach, the company employs over 95,000 people across more than 150 countries. This vast operational scale not only underpins its comprehensive approach to healthcare but also highlights the importance of financial strategies that enable sustained growth and technological advancement. Investors and healthcare professionals alike are expected to pay close attention to the insights shared during these conferences, which will serve as a reflection of Medtronic’s vision for the future and its approach to navigating potential risks and uncertainties intrinsic to the healthcare sector.

In parallel with the discussions at these conferences, Medtronic remains committed to transparent communication with its stakeholders. The company encourages interested parties to refer to their periodic reports filed with the Securities and Exchange Commission to better understand potential risks and actual performance results. For media inquiries, Justin Paquette is the point of contact, while Ingrid Goldberg handles investor relations, ensuring that all questions regarding Medtronic's ongoing commitments are addressed comprehensively.